DB01 - Hypercortisolism in Uncontrolled Type 2 Diabetes: Pathogenic Driver or Bystander?

Saturday, June 13, 2026

10:45 AM - 12:15 PM CT

Location: Room W375C

Debate Moderator(s)

Alvin Powers, MD

Co-Director, Vanderbilt Diabetes Center, Prof of Med and Molec Physio
Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Alvin C. Powers, MD: No financial relationships to disclose

Does hypercortisolism in uncontrolled type 2 diabetes represent an adaptive physiologic response or a previously underappreciated driver of metabolic dysfunction? This debate brings together leading experts to examine emerging evidence at the intersection of endocrinology and metabolism, with important implications for screening, diagnosis, and therapeutic intervention in patients with poorly controlled diabetes.

Presentations:

10:45 AM - 10:55 AM CT

Vigersky Outstanding Clinical Practitioner Award Presentation
Awardee: Lisa Nachtigall, MD (she/her/hers) – Mass General Brigham Pituitary Center
10:45 AM - 12:15 PM CT

Hypercortisolism in Uncontrolled Type 2 Diabetes: Pathogenic Driver or Bystander?
Debate Speaker: Marie E. McDonnell, MD – Brigham and Women's Hospital
10:45 AM - 12:15 PM CT

Hypercortisolism in Uncontrolled Type 2 Diabetes: Pathogenic Driver or Bystander?
Debate Speaker: James W. Findling, MD – Medical College of Wisconsin